TABLE 1.

Characteristics of patients included in the severity analysis cohort

Study	Country	Sample Size	Severe patients				Non-severe patients
			n (%)	Age (yrs)*	Women (%)	CVD n (%)	n (%)	Age (yrs)*	Women (%)	CVD n (%)
Aggarwal et al. (2020)	Iowa, USA	16	8 (50%)	67 (38-70)	3 (38%)	5 (63%)	8 (50%)	68.5 (41-95)	1 (13%)	2 (26%)
Li et al. (2020)	Wuhan, China	548	269 (49.1%)	65	116 (43.1%)	28 (10.4%)	279 (50.9%)	56	153 (54.8%)	6 (2.2%)
Goyal et al. (2020)	New York, USA	393	130 (33.1%)	64.5	32 (28.2%)	25 (19.2%)	263 (66.9%)	61.5	117 (44.5%)	29 (11%)
Guan et al. (2020)	Outside Hubei, China	1099	173 (15.7%)	52 (40–65)	73 (42%)	10 (5.8%)	926 (84.3%)	45 (34-57)	386 (42%)	17 (1.8%)
Huang et al. (2020)	Wuhan, China	41	13 (31.7%)	49 (41-61)	2 (15%)	3 (23%)	28 (68.3%)	49 (41-57.5)	9 (32%)	3 (11%)
Liu et al. (2020)	Shenzen, China	12	6 (50%)	64	3 (50%)	3 (50%)	6 (50%)	43.3	1 (16%)	1 (16%)
Qin et al. (2020)	Wuhan, China	452	286 (63.3%)	61 (51-69)	131 (45.8%)	24 (8.4%)	166 (36.7%)	53 (41.25-62)	86 (51.8%)	3 (1.8%)
Wan et al. (2020)	Chongqing, China	135	40 (29.6%)	56 (52-73)	19 (47.5%)	6 (15%)	95 (70.4%)	44 (33-49)	43 (45.3%)	1 (1%)
Wang D et al. (2020)	Wuhan, China	138	36 (26.1%)	66 (57-78)	14 (39%)	9 (25%)	102 (73.9%)	51 (37-62)	49 (48%)	11 (10.8%)
Wu et al. (2020)	Wuhan, China	201	84 (41.7%)	58.5 (50-69)	24 (28.6%)	5 (6%)	117 (58.3%)	48 (40-54)	49 (41.9%)	3 (2.6%)
Zhang et al. (2020)	Wuhan, China	140	58 (41.4%)	64 (25-87)	25 (43%)	4 (6.9%)	82 (58.6%)	52 (26-78)	44 (54%)	3 (3.7%)
Feng et al. (2020)	Wuhan, China	476	124 (26.1%)	58 (48-67)	43 (34.7%)	17 (13.7%)	352 (73.9%)	51 (37-63)	162 (46%)	21 (6%)
Zheng et al. (2020)	Changsha, China	161	30 (18.6%)	57 (46.5-66)	16 (53.3%)	2 (6.7%)	131 (81.4%)	40 (31-51)	65 (49.6%)	2 (1.5%)